Trials / Unknown
UnknownNCT00551226
Follow up of Autoantibodies in Active Tuberculosis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
We have previoulsy shown that patients with active Tuberculosis develop a wide array of autoantibodies including rheumatoid factor, anti-CCP, Antinuclear facyor and anti Sm antibodies. The purpose of this study is to evaluate whether the level of autoantibodies decrease after treatment aganist tuberculosis.
Conditions
Timeline
- Start date
- 2007-11-01
- Completion
- 2008-11-01
- First posted
- 2007-10-30
- Last updated
- 2007-10-30
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00551226. Inclusion in this directory is not an endorsement.